Intrinsic Value of S&P & Nasdaq Contact Us

Alaunos Therapeutics, Inc. TCRT NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
41/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — TCRT

Alaunos Therapeutics, Inc. (TCRT) has a market capitalization of $6.87M and trades at $2.89. The 52-week range is 1.67-6.2.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.3, Earnings Per Share (EPS) of $-2.20, annual revenue of $5K.

The stock has a beta of -1.29, operates in the Healthcare sector.

Trading Data
Current Price$2.89
52-Week Range1.67-6.2
Volume21.01K
Avg Volume (30D)16.01K
Market Cap$6.87M
Beta (1Y)-1.29
Company
IPO Date2005-08-24
Employees1
CEOFerdinand Groenewald
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS98973P3091
CUSIP98973P101
Income (Latest Year)
Revenue$5K
EBITDA$-4.23M
Operating Income$-4.23M
Net Income$-4.18M
EPS$-2.20
EPS Diluted$-2.20
Shares Outstanding$1.95M
Balance Sheet (Latest Year)
Total Assets$2.97M
Current Assets$1.99M
Cash & ST Investments$1.39M
Total Liabilities$813K
Net Debt$-1.39M
Total Equity$2.15M
Valuation Ratios
P/E Ratio-1.3
P/S Ratio1374.63
P/B Ratio3.19
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message